ProQuest Associates IV’s Anthera Pharmaceuticals, Inc. ANTH Stock Holding History

ProQuest Associates IV’s Portfolio ANTH Stock Details ANTH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-237,500	Closed	-$5.99M	–	4
2016 Q3	$5.99M	Hold	237,500	–	–	1.65%	4
2016 Q2	$5.87M	Hold	237,500	–	–	2.39%	4
2016 Q1	$6.88M	Hold	237,500	–	–	2.67%	4
2015 Q4	$8.82M	Hold	237,500	–	–	1.7%	4
2015 Q3	$11.6M	Hold	237,500	–	–	2.74%	4
2015 Q2	$16.4M	Hold	237,500	–	–	3.36%	4
2015 Q1	$8.49M	Buy	237,500 +81,250	+52%	+$2.4M	2.77%	4
2014 Q4	$1.98M	Buy	+156,250	New	+$2.27M	1%	5

Other funds holding ANTH

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

ProQuest Associates IV's ANTH Position: Q4 2016 in Review

ProQuest Associates IV sold out of Anthera Pharmaceuticals, Inc. (ANTH) in Q4 2016, closing a stake of 237,500 shares — an estimated $5.99M sold.

ProQuest Associates IV first reported a position in ANTH in Q4 2014 and held it in 8 quarters. The position peaked at $16.4M in Q2 2015. 72 funds tracked by Wall St. Rank hold ANTH as of Q4 2016.

ProQuest Associates IV reported no remaining Anthera Pharmaceuticals, Inc. position as of Q4 2016 after selling out during the quarter.
ProQuest Associates IV sold 237,500 Anthera Pharmaceuticals, Inc. shares in Q4 2016, an estimated $5.99M.
ProQuest Associates IV first reported a position in Anthera Pharmaceuticals, Inc. in Q4 2014 and held it in 8 quarters.
ProQuest Associates IV's Anthera Pharmaceuticals, Inc. position peaked at $16.4M in Q2 2015.
72 funds tracked by Wall St. Rank held Anthera Pharmaceuticals, Inc. as of Q4 2016.

Based on ProQuest Associates IV's 13F filing for Q4 2016, filed 14 Feb 2017.